Literature DB >> 20425025

Gout, hyperuricemia, and Parkinson's disease: a protective effect?

Alvaro Alonso1, Kelly A Sovell.   

Abstract

Oxidative stress is potentially involved in the pathogenesis of Parkinson's disease (PD). Serum uric acid, because of its antioxidant effect, might prevent the development of this neurodegenerative disorder. Indeed, a number of epidemiologic studies have consistently reported a strong inverse association between serum uric acid and the risk of PD. The risk of PD is also lower among individuals with gout. In addition, suggestive evidence from clinical studies shows high levels of uric acid as a marker of better prognosis in PD. Future research should determine the mechanisms underlying this association. This, in turn, could be used in the development of new preventive strategies and treatments for PD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425025     DOI: 10.1007/s11926-010-0083-4

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  21 in total

Review 1.  Diagnosis and treatment of Parkinson disease: molecules to medicine.

Authors:  Joseph M Savitt; Valina L Dawson; Ted M Dawson
Journal:  J Clin Invest       Date:  2006-07       Impact factor: 14.808

2.  Serum uric acid levels and the risk of Parkinson disease.

Authors:  Lonneke M L de Lau; Peter J Koudstaal; Albert Hofman; Monique M B Breteler
Journal:  Ann Neurol       Date:  2005-11       Impact factor: 10.422

3.  Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.

Authors:  Gwen S Scott; Sergei V Spitsin; Rhonda B Kean; Tatiana Mikheeva; Hilary Koprowski; D Craig Hooper
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-25       Impact factor: 11.205

4.  How common are the "common" neurologic disorders?

Authors:  D Hirtz; D J Thurman; K Gwinn-Hardy; M Mohamed; A R Chaudhuri; R Zalutsky
Journal:  Neurology       Date:  2007-01-30       Impact factor: 9.910

5.  Inosine reduces ischemic brain injury in rats.

Authors:  Hui Shen; Guann-Juh Chen; Brandon K Harvey; Paula C Bickford; Yun Wang
Journal:  Stroke       Date:  2005-02-03       Impact factor: 7.914

6.  The treatment of multiple sclerosis with inosine.

Authors:  Clyde E Markowitz; Sergei Spitsin; Vanessa Zimmerman; Dina Jacobs; Jayaram K Udupa; D Craig Hooper; Hilary Koprowski
Journal:  J Altern Complement Med       Date:  2009-06       Impact factor: 2.579

7.  No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease.

Authors:  J E Ahlskog; R J Uitti; P A Low; G M Tyce; K K Nickander; R C Petersen; E Kokmen
Journal:  Mov Disord       Date:  1995-09       Impact factor: 10.338

8.  Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.

Authors:  B N Ames; R Cathcart; E Schwiers; P Hochstein
Journal:  Proc Natl Acad Sci U S A       Date:  1981-11       Impact factor: 11.205

9.  Plasma urate and progression of mild cognitive impairment.

Authors:  Michael C Irizarry; Rema Raman; Michael A Schwarzschild; Lida M Becerra; Ronald G Thomas; Ronald C Peterson; Alberto Ascherio; Paul S Aisen
Journal:  Neurodegener Dis       Date:  2008-11-05       Impact factor: 2.977

10.  Uric acid associates with cognition in Parkinson's disease.

Authors:  Tua Annanmaki; Anniina Pessala-Driver; Laura Hokkanen; Kari Murros
Journal:  Parkinsonism Relat Disord       Date:  2008-03-05       Impact factor: 4.891

View more
  8 in total

1.  Gout and open-angle glaucoma risk in a veteran population.

Authors:  Kristin S Biggerstaff; Donna L White; Benjamin J Frankfort; Peter Richardson; Silvia Orengo-Nania; Jose Garcia; Elizabeth Y Chiao; Jennifer R Kramer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-07-17       Impact factor: 3.117

Review 2.  The significance of uric acid in the diagnosis and treatment of Parkinson disease: An updated systemic review.

Authors:  Zhange Yu; Shuai Zhang; Dongdong Wang; Meng Fan; Fuqiang Gao; Wei Sun; Zirong Li; Shiliang Li
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

Review 3.  Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studies.

Authors:  Xue Li; Xiangrui Meng; Maria Timofeeva; Ioanna Tzoulaki; Konstantinos K Tsilidis; John PA Ioannidis; Harry Campbell; Evropi Theodoratou
Journal:  BMJ       Date:  2017-06-07

Review 4.  Recent advances in understanding and managing gout.

Authors:  Talia F Igel; Svetlana Krasnokutsky; Michael H Pillinger
Journal:  F1000Res       Date:  2017-03-10

5.  Relationship between oxidative stress and inflammation in hyperuricemia: Analysis based on asymptomatic young patients with primary hyperuricemia.

Authors:  You Zhou; Mingcai Zhao; Zheyan Pu; Guoqiang Xu; Xiangkun Li
Journal:  Medicine (Baltimore)       Date:  2018-12       Impact factor: 1.817

6.  Low uric acid levels in patients with Parkinson's disease: evidence from meta-analysis.

Authors:  Liang Shen; Hong-Fang Ji
Journal:  BMJ Open       Date:  2013-11-18       Impact factor: 2.692

7.  Serum Uric Acid, Serum Uric Acid to Serum Creatinine Ratio and Serum Bilirubin in Patients With Parkinson's Disease: A Case-Control Study.

Authors:  Chayanon Songsomboon; Surat Tanprawate; Atiwat Soontornpun; Chayasak Wantaneeyawong; Worawit Louthrenoo
Journal:  J Clin Med Res       Date:  2020-03-02

8.  Diabetes, a Contemporary Risk for Parkinson's Disease: Epidemiological and Cellular Evidences.

Authors:  Domenico Sergi; Justine Renaud; Nicola Simola; Maria-Grazia Martinoli
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.